Size
of LDL and HDL Particles and Esterification Rate of Cholesterol in Patients after
Transplantation of the Kidneys: Abnormalities in the Plasma Lipoprotein Profile
Ptáčková K.1, Teplan V., Stříbrná J., Dobiášová M., Schück O., Štollová M.,
Fyziologický ústav Akademie věd ČR, Praha, Klinika nefrologie, TC, Institut klinické a experimentální medicíny, Praha, Transplant centrum, Institut klinické a experimentální medicíny, Praha |
|
Summary:
Renal transplantations are often complicated by cardiovascular diseases. These complications are frequently
associated with hyperlipidaemia. However, the reason for the high incidence of cardiovascular disease in renal
transplant recipients who have roughly normal concentrations of plasma lipids has to be determined.
We measured plasma lipid parameters, HDL and LDL particle size and the fractional esterification rate of
cholesterol in plasma depleted of apoB containing apoproteins (FERHDL) in 40 subjects (23 men and 17 women),
who underwent successful kidney transplantation 24 or more months before the date of assessment. The patients
were selected from a group of renal transplant recipients of the Department of Nephrology (Institute of Clinical
and Experimental Medicine, Prague). The criterion for selection was normal pre-transplant plasma HDL
cholesterol (HDL-C). Basic plasma lipid parameters (total cholesterol TC, HDL-C, triglycerides (TG), LDL-C were
compared at 3 occasions: before kidney transplantation (A), 6 months after transplantation (B) and 24 and more
months after transplantation (C). Standard enzymatic methods were applied for estimation TC, TG and gradient
gel electrophoresis for determination of lipoproteins particle size. FERHDL was determined using radioassay. In
the interval AB increased significantly: body mass index BMI (from 23.4±3.8 to 25.7±4.0, p < 0.001), TC levels (from
5.4±1.3 to 6.6±1.3 mmol/L, p < 0.001) and TG (from 1.7±0.7 to 2.4±1.2 mmol/L, p < 0.001). HDL and LDL cholesterol
remained unchanged. In interval BC we observed a significant decrease of plasma TC (from 6.6±1.3 to 5:8±1.2
mmol/L, p < 0.002), TG (from 2.36±1.2 to 1.4±0.7 mmol/L, p < 0.001) and HDL-C (from 1.67±0.38 to 1.17±0.25,p < 0.0001). No changes in LDL-C and BMI were noticed in the B,C interval. The atherogenic index of plasma
despite of significant differences in TG and HDL-C concentrations remained without change. The size of HDL
and FERHDL values measured 24 and more months after transplantation were not different from those in control
subjects. However, LDL particle size was within the range of the atherogenic B plasma type in 33 out of 40 subjects.
Correlation analysis showed abnormalities in relations between LDL sizes, TG and FE RHDL. In healthy subjects
there is a very close correlation between FERHDL and TG levels and inverse correlation between and LDL size.
In renal transplant recipients only the correlation between FERHDL and HDL-C was significant (R = -0.67, p <
0.001).
Key words:
HDL sub-populations, LDL size, renal transplant recipients, cholesterol esterification rate
(FERHDL), cardiovascular disease.
|